219 related articles for article (PubMed ID: 16575855)
1. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin.
Louneva N; Huaman G; Fertala J; Jiménez SA
Arthritis Rheum; 2006 Apr; 54(4):1298-308. PubMed ID: 16575855
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice.
Christner PJ; Hitraya EG; Peters J; McGrath R; Jiménez SA
Arthritis Rheum; 1998 Dec; 41(12):2132-42. PubMed ID: 9870870
[TBL] [Abstract][Full Text] [Related]
3. CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts.
Saitta B; Gaidarova S; Cicchillitti L; Jimenez SA
Arthritis Rheum; 2000 Oct; 43(10):2219-29. PubMed ID: 11037881
[TBL] [Abstract][Full Text] [Related]
4. EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.
Ikeda H; Sunazuka T; Suzuki H; Hamasaki Y; Yamazaki S; Omura S; Hatamochi A
J Dermatol Sci; 2008 Mar; 49(3):195-205. PubMed ID: 18036782
[TBL] [Abstract][Full Text] [Related]
5. Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis.
Hitraya EG; Varga J; Artlett CM; Jiménez SA
Arthritis Rheum; 1998 Nov; 41(11):2048-58. PubMed ID: 9811061
[TBL] [Abstract][Full Text] [Related]
6. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene.
Ihn H; Tamaki K
Arthritis Rheum; 2000 Oct; 43(10):2240-7. PubMed ID: 11037883
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I.
Rosenbloom J; Saitta B; Gaidarova S; Sandorfi N; Rosenbloom JC; Abrams WR; Hamilton AD; Sebti SM; Kucich U; Jimenez SA
Arthritis Rheum; 2000 Jul; 43(7):1624-32. PubMed ID: 10902768
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Yokota K; Miyazaki T; Hirano M; Akiyama Y; Mimura T
J Rheumatol; 2006 Mar; 33(3):463-71. PubMed ID: 16511915
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycin.
Sandorfi N; Louneva N; Hitraya E; Hajnoczky G; Saitta B; Jimenez SA
Ann Rheum Dis; 2005 Dec; 64(12):1685-91. PubMed ID: 15901633
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.
Burke JP; Watson RW; Murphy M; Docherty NG; Coffey JC; O'Connell PR
Br J Surg; 2009 May; 96(5):541-51. PubMed ID: 19358180
[TBL] [Abstract][Full Text] [Related]
12. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
Hu WL; Qiao SB; Li JJ
Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts.
Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
Arthritis Rheum; 2005 Apr; 52(4):1237-47. PubMed ID: 15818662
[TBL] [Abstract][Full Text] [Related]
15. Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts.
Dooley A; Gao B; Shi-Wen X; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR
Free Radic Biol Med; 2007 Jul; 43(2):253-64. PubMed ID: 17603934
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
17. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
Ihn H; Yamane K; Kubo M; Tamaki K
Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures.
Ruiz-Gaspa S; Nogues X; Enjuanes A; Monllau JC; Blanch J; Carreras R; Mellibovsky L; Grinberg D; Balcells S; Díez-Perez A; Pedro-Botet J
J Cell Biochem; 2007 Aug; 101(6):1430-8. PubMed ID: 17252541
[TBL] [Abstract][Full Text] [Related]
19. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
